[go: up one dir, main page]

DE60132256D1 - Wasser-absorbierende polymere und ihre verwendung - Google Patents

Wasser-absorbierende polymere und ihre verwendung

Info

Publication number
DE60132256D1
DE60132256D1 DE60132256T DE60132256T DE60132256D1 DE 60132256 D1 DE60132256 D1 DE 60132256D1 DE 60132256 T DE60132256 T DE 60132256T DE 60132256 T DE60132256 T DE 60132256T DE 60132256 D1 DE60132256 D1 DE 60132256D1
Authority
DE
Germany
Prior art keywords
water absorbent
absorbent polymers
polymers
water
absorbent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60132256T
Other languages
English (en)
Other versions
DE60132256T2 (de
Inventor
Jaime Simon
Alan D Strickland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sorbent Therapeutics Inc
Original Assignee
Sorbent Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorbent Therapeutics Inc filed Critical Sorbent Therapeutics Inc
Publication of DE60132256D1 publication Critical patent/DE60132256D1/de
Application granted granted Critical
Publication of DE60132256T2 publication Critical patent/DE60132256T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE60132256T 2000-11-20 2001-11-06 Wasserabsorbierende polymere und deren verwendung Expired - Lifetime DE60132256T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24995500P 2000-11-20 2000-11-20
US249955P 2000-11-20
PCT/US2001/051233 WO2002040039A2 (en) 2000-11-20 2001-11-06 In vivo use of water absorbent polymers

Publications (2)

Publication Number Publication Date
DE60132256D1 true DE60132256D1 (de) 2008-02-14
DE60132256T2 DE60132256T2 (de) 2008-12-24

Family

ID=22945717

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132256T Expired - Lifetime DE60132256T2 (de) 2000-11-20 2001-11-06 Wasserabsorbierende polymere und deren verwendung

Country Status (7)

Country Link
US (2) US6908609B2 (de)
EP (2) EP2324861A1 (de)
JP (3) JP2004517066A (de)
AU (1) AU2002232955A1 (de)
CA (1) CA2428800C (de)
DE (1) DE60132256T2 (de)
WO (1) WO2002040039A2 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
AU2002232955A1 (en) * 2000-11-20 2002-05-27 Dow Global Technologies Inc. In vivo use of water absorbent polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
PL2269589T3 (pl) 2004-03-30 2014-05-30 Relypsa Inc Polimery wiążące jony i ich zastosowania
BRPI0509366B8 (pt) * 2004-03-30 2021-05-25 Ilypsa Inc composição farmacêutica, kit farmacêutico, e, uso de uma composição farmacêutica
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) * 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
WO2005105068A1 (en) * 2004-04-15 2005-11-10 Dow Global Technologies Inc. In vivo stimulation of intestinal transporters for excretion of nitrogenous wastes
US20050244367A1 (en) * 2004-05-03 2005-11-03 Ilypsa, Inc. Phospholipase inhibitors localized in the gastrointestinal lumen
US8202248B2 (en) 2004-08-18 2012-06-19 Sequana Medical Ag Dialysis implant and methods of use
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
TWI522092B (zh) * 2005-02-28 2016-02-21 贏創德固賽有限責任公司 丙烯酸和基於可再生原料之吸水聚合物結構及二者之製備方法
US20070196321A1 (en) * 2005-04-12 2007-08-23 Strickland Alan D In vivo stimulation of intestinal transporters for excretion of nitrogenous wastes
WO2007016377A2 (en) * 2005-07-28 2007-02-08 Dow Global Technologies Inc. Dialysis solution including water-soluble polyelectrolyte osmotic agent
EP1951266A2 (de) * 2005-09-02 2008-08-06 Genzyme Corporation Verfahren zur entfernung von phosphat und dafür verwendetes polymer
CN101272762B (zh) 2005-09-15 2013-02-06 基酶有限公司 胺聚合物的小袋制剂
GB2446076B (en) * 2005-09-30 2010-11-24 Ilypsa Inc Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
CN101316601A (zh) * 2005-09-30 2008-12-03 伊立普萨公司 从哺乳动物的胃肠道选择性除去钾离子的方法和组合物
EP1776966A1 (de) * 2005-10-21 2007-04-25 The Procter and Gamble Company Absorbierender Artikel mit erhöhter Fähigkeit proteinhaltige oder seröse Körperflüssigkeiten zu absorbieren und zurückhalten
MX2008006233A (es) 2005-11-14 2008-10-03 Valorisation Rech Ltd Partners Composiciones farmaceuticas que comprenden aglutinantes polimericos con enlaces covalentes no hidrlizables y su uso en el tratamiento de la enfermedad celiaca.
NZ569756A (en) 2005-12-12 2011-07-29 Allaccem Inc Methods and systems for preparing antimicrobial films and coatings utilising polycyclic bridged ammonium salts
JP2009536246A (ja) * 2006-05-05 2009-10-08 ゲンズイメ コーポレーション ホスフェート捕捉剤としてのアミン縮合重合体
BRPI0715053A2 (pt) * 2006-07-18 2013-03-19 Genzyme Corp composiÇço farmacÊutica, mÉtodo para tratar doenÇas, e, polÍmero
WO2008009612A1 (de) * 2006-07-19 2008-01-24 Basf Se Verfahren zur herstellung wasserabsorbierender polymerpartikel mit hoher permeabilität durch polymerisation von tropfen einer monomerlösung
US8425887B2 (en) 2006-09-29 2013-04-23 Genzyme Corporation Amide dendrimer compositions
US8529805B2 (en) * 2006-10-05 2013-09-10 Basf Se Method for the production of water absorbent polymer particles by polymerizing drops of a monomer solution
EP2120972A1 (de) 2006-12-14 2009-11-25 Genzyme Corporation Amido-amin-polymerzusammensetzungen
EP2125026B1 (de) 2007-02-21 2014-09-24 AllAccem, Inc. Auf verbrückter polycyclischer verbindung basierende zusammensetzungen zur hemmung und linderung von erkrankungen
JP2010519298A (ja) * 2007-02-23 2010-06-03 ゲンズイメ コーポレーション アミンポリマー組成物
WO2008109095A1 (en) * 2007-03-08 2008-09-12 Genzyme Corporation Sulfone polymer compositions
WO2008133954A1 (en) * 2007-04-27 2008-11-06 Genzyme Corporation Amido-amine dendrimer compositions
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
MX2010002256A (es) * 2007-08-29 2010-06-23 Sorbent Therapeutics Inc Composiciones polimericas absorbentes con contenido variable de contraiones y sus metodos de preparacion y uso.
US20100316589A1 (en) * 2007-12-14 2010-12-16 Hitesh Bhagat Coated Pharmaceutical Compositions
US8220643B2 (en) 2008-06-06 2012-07-17 Fresenius Medical Care Holdings, Inc. Urea sorbent
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
US20110142952A1 (en) * 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
US20110236340A1 (en) * 2008-08-22 2011-09-29 Relypsa, Inc. Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia
US8337824B2 (en) 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
WO2010022381A1 (en) * 2008-08-22 2010-02-25 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10543207B2 (en) 2008-12-31 2020-01-28 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
HRP20180289T1 (hr) 2008-12-31 2018-03-23 Ardelyx, Inc. Spojevi i postupci za inhibiciju antiporta posredovanu s pomoću nhe pri liječenju poremećaja povezanih sa zadržavanjem tekućine ili prevelikom količinom soli i poremećajima gastrointestinalnog trakta
CN102641496A (zh) * 2011-02-16 2012-08-22 辛绍祺 高分子聚合物的新用途及其组成物
ES2782523T3 (es) * 2011-08-01 2020-09-15 Hb Biotechnologies Corp Cápsulas no digeribles para la administración de materiales absorbentes de líquido
US8585635B2 (en) * 2012-02-15 2013-11-19 Sequana Medical Ag Systems and methods for treating chronic liver failure based on peritoneal dialysis
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP2887964B1 (de) 2012-08-21 2019-07-03 Ardelyx, Inc. Verbindungen und verfahren zur hemmung von nhe-vermitteltem antiport bei der behandlung von erkrankungen im zusammenhang mit flüssigkeitsretention oder salzüberlastung und erkrankungen des gastrointestinaltraktes
KR20210005314A (ko) 2012-10-08 2021-01-13 리립사, 인크. 고혈압 및 고칼륨혈증을 치료하기 위한 칼륨-결합제
PL2983667T3 (pl) 2013-04-12 2019-10-31 Ardelyx Inc Związki wiążące nhe3 oraz sposoby inhibicji transportu fosforanów
US10251993B2 (en) 2016-02-26 2019-04-09 Feng Chen Hemodialysis device
JP7071338B2 (ja) 2016-08-26 2022-05-18 セクアナ メディカル エヌブイ 埋め込み型装置によって生成されたデータを管理及び分析するためのシステム及び方法
JP7292207B2 (ja) 2017-01-09 2023-06-16 アルデリックス， インコーポレイテッド 消化管障害を処置するために有用な化合物
WO2018129557A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Inhibitors of nhe-mediated antiport
US11559618B2 (en) 2017-05-24 2023-01-24 Sequana Medical Nv Formulations and methods for direct sodium removal in patients having severe renal dysfunction
US20200261494A1 (en) * 2017-11-01 2020-08-20 Isotherapeutics Group Llc Solid oral formulation and method to treat cases of fluid overload in animals

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2491475A (en) * 1946-03-25 1949-12-20 Parke Davis & Co Enteric capsule
US2909462A (en) * 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
DE1070381B (de) * 1957-03-15 1959-12-03 Rohm & LIaas Company, Philadelphia, Pa. (V. St. A.) Verfahren zur Herstellung von Ionenaustauscherharzen auf Basis der Acrylsäuren und Methacrylsäuren
US3297031A (en) * 1966-02-07 1967-01-10 Henry F Bray Suppository applicator
US3692914A (en) * 1970-06-22 1972-09-19 Hoechst Co American 4,4{40 ,4{41 -trihydroxytriphenylmethylmethane as a laxative
US3842022A (en) * 1973-08-06 1974-10-15 Dow Chemical Co Polymeric acrylic acid-urea complexes and preparation
US3926891A (en) 1974-03-13 1975-12-16 Dow Chemical Co Method for making a crosslinkable aqueous solution which is useful to form soft, water-swellable polyacrylate articles
US3997484A (en) 1974-04-03 1976-12-14 The United States Of America As Represented By The Secretary Of Agriculture Highly-absorbent starch-containing polymeric compositions
US3935099A (en) 1974-04-03 1976-01-27 The United States Of America As Represented By The Secretary Of Agriculture Method of reducing water content of emulsions, suspensions, and dispersions with highly absorbent starch-containing polymeric compositions
US4090013A (en) 1975-03-07 1978-05-16 National Starch And Chemical Corp. Absorbent composition of matter
JPS51125468A (en) 1975-03-27 1976-11-01 Sanyo Chem Ind Ltd Method of preparing resins of high water absorbency
JPS5346389A (en) 1976-10-07 1978-04-25 Kao Corp Preparation of self-crosslinking polymer of acrylic alkali metal salt
US4190562A (en) 1977-04-04 1980-02-26 The B. F. Goodrich Company Improved water absorbent copolymers of copolymerizable carboxylic acids and acrylic or methacrylic esters
NL7703937A (nl) * 1977-04-12 1978-10-16 Organon Teknika Bv Inrichting voorzien van een sorbent voor het zuiveren van bloed; een voor orale toepassing geschikt sorbent en een werkwijze voor vervaar- diging van het sorbent.
US4143130A (en) * 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
US4470975A (en) * 1977-10-21 1984-09-11 The Johns Hopkins University Method and composition for the elimination of water from an animal body
US4286082A (en) 1979-04-06 1981-08-25 Nippon Shokubai Kagaku Kogyo & Co., Ltd. Absorbent resin composition and process for producing same
JPS6025045B2 (ja) 1980-03-19 1985-06-15 製鉄化学工業株式会社 塩水吸収能のすぐれたアクリル酸重合体の製造方法
JPS57158209A (en) 1981-03-25 1982-09-30 Kao Corp Production of bead-form highly water-absorbing polymer
JPS5832607A (ja) 1981-08-20 1983-02-25 Kao Corp 吸水性に優れた吸水材料の製造法
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
US4985518A (en) 1981-10-26 1991-01-15 American Colloid Company Process for preparing water-absorbing resins
US4556552A (en) 1983-09-19 1985-12-03 Colorcon, Inc. Enteric film-coating compositions
JPS6090243A (ja) 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
JPS6187702A (ja) 1984-10-05 1986-05-06 Seitetsu Kagaku Co Ltd 吸水性樹脂の製造方法
US4654039A (en) * 1985-06-18 1987-03-31 The Proctor & Gamble Company Hydrogel-forming polymer compositions for use in absorbent structures
EP0314825B1 (de) 1987-11-03 1993-02-17 The Dow Chemical Company Wasserabsorbierende Polymerperlen, Verfahren zu deren Herstellung und Suspendiermittel, die dabei verwendet werden
US4708997A (en) 1985-07-22 1987-11-24 The Dow Chemical Company Suspending agent for the suspension polymerization of water-soluble monomers
US4833198A (en) 1985-07-22 1989-05-23 The Dow Chemical Company Suspending agent for the suspension polymerization of water-soluble monomers
DE3544770A1 (de) 1985-12-18 1987-06-19 Stockhausen Chem Fab Gmbh Verfahren und vorrichtung zum kontinuierlichen herstellen von polymerisaten und copolymerisaten der acrylsaeure und/oder methacrylsaeure
DE3767514D1 (de) * 1986-03-11 1991-02-28 Thompson Barry Antony Fuettern von vieh mit polymeren.
EP0273209B1 (de) * 1986-12-30 1992-01-15 American Cyanamid Company Zusammensetzung die ein Polycarbophil enthält
JP2579494B2 (ja) 1987-08-31 1997-02-05 富士通株式会社 Ｓｏｉウエハの製造方法
US4861849A (en) * 1988-01-15 1989-08-29 The Dow Chemical Company Sodium thiosulfate as part of a redox initiator system for the polymerization of water-swellable polymers
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
US5145906A (en) 1989-09-28 1992-09-08 Hoechst Celanese Corporation Super-absorbent polymer having improved absorbency properties
BE1003677A3 (nl) 1990-01-29 1992-05-19 Schacht Etienne Werkwijze voor het bereiden van azobevattende polymeren en het gebruik ervan als geneesmiddelafgiftesystemen.
JPH05505851A (ja) * 1990-12-07 1993-08-26 インペリアル　ケミカル　インダストリーズ　ピーエルシー 窒素誘導体
IE914179A1 (en) * 1990-12-07 1992-06-17 Ici Plc Nitrogen derivatives
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
AU692432B2 (en) * 1993-02-17 1998-06-11 British Technology Group Limited Polymeric compounds
US5629377A (en) 1993-03-10 1997-05-13 The Dow Chemical Company Water absorbent resin particles of crosslinked carboxyl containing polymers and method of preparation
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5618530A (en) 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
GB9317867D0 (en) 1993-08-27 1993-10-13 Dow Deutschland Inc Aqueous fluid absorbent polymers having a superior balance of absorpitive properties
US6204243B1 (en) 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US6333399B1 (en) * 1995-02-13 2001-12-25 Alexander Teslenko Process for producing chitosan-glucan complexes, compounds producible therefrom and their use
JPH08256387A (ja) 1995-03-17 1996-10-01 Miyuu:Kk ワイヤレスリモコンの中継器
JPH08286446A (ja) 1995-04-18 1996-11-01 Ricoh Co Ltd 機器本体
JPH08337726A (ja) * 1995-06-14 1996-12-24 Kao Corp 高吸水性樹脂及び吸収性物品
FR2744456A1 (fr) * 1996-02-07 1997-08-08 Atochem Elf Sa Polymeres superabsorbants a structure coeur-coquille et leur procede d'obtention
JP3885130B2 (ja) 1996-06-11 2007-02-21 株式会社大塚製薬工場 グアニジノ化合物低下剤並びに水分及びカリウムイオン吸着剤
NZ335329A (en) 1996-10-23 2001-06-29 Dow Chemical Co Water soluble polyether glycol polymer capable of complexing phosphate or oxalate used for reduction of dietary phosphate or oxalate absorption
JPH10130154A (ja) 1996-10-29 1998-05-19 Otsuka Pharmaceut Factory Inc 腎疾患患者用延命率改善薬
KR20010102350A (ko) 1999-02-24 2001-11-15 그래햄 이. 테일러 높은 내부 상 에멀젼에서 초흡수제의 제조방법
AU2002232955A1 (en) * 2000-11-20 2002-05-27 Dow Global Technologies Inc. In vivo use of water absorbent polymers
US11451716B2 (en) 2021-01-25 2022-09-20 Hand Held Products, Inc. Illumination control for imaging systems with multiple image sensors

Also Published As

Publication number Publication date
JP2004517066A (ja) 2004-06-10
US6908609B2 (en) 2005-06-21
WO2002040039A3 (en) 2003-11-06
EP2324861A1 (de) 2011-05-25
EP1381376B1 (de) 2008-01-02
CA2428800C (en) 2011-09-13
CA2428800A1 (en) 2002-05-23
AU2002232955A1 (en) 2002-05-27
US20020146386A1 (en) 2002-10-10
WO2002040039A2 (en) 2002-05-23
JP2010163467A (ja) 2010-07-29
US20050036983A1 (en) 2005-02-17
EP1381376A2 (de) 2004-01-21
DE60132256T2 (de) 2008-12-24
JP2014156492A (ja) 2014-08-28

Similar Documents

Publication Publication Date Title
DE60132256D1 (de) Wasser-absorbierende polymere und ihre verwendung
DE60121609D1 (de) Modifiziertes polyolefinharz, modifizierte polyolefinharzzusammensetzung und ihre verwendung
DE60106423D1 (de) Entzündungshemmende verbindungen und ihre verwendung
ATE548397T1 (de) Strukturell modifizierte polymere flockungsmittel
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
DE50002697D1 (de) Copolymere und ihre Verwendung als Bohrhilfsmittel
DE50112013D1 (de) Deodorantien und antiperspirantien
DE60103974D1 (de) Gyrase-inhibitoren und ihre verwendung
ATE522506T1 (de) 4-aminopicolinate und ihre verwendung als herbizide
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
DE60016326D1 (de) Wasser-absorbierende Zusammensetzung und ihre Verwendung
NO20031129L (no) Human koagulasjonsfaktor VII-varianter
DE60209486D1 (de) Pyranoindazole und ihre verwendung in der glaukombehandlung
ATE332294T1 (de) Dihydro-1,3,5-triazin-diamin-derivate und ihre therapeutische verwendung
DE50111690D1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
ATE329906T1 (de) Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren
DE60140133D1 (de) Polymere
ATE456657T1 (de) Aromatische methyltransferasen und ihre verwendung
DE60027927D1 (de) Harzstruktur und ihre verwendung
DE60112635D1 (de) Ölzusammensetzung und ihre Verwendung
ATE420642T1 (de) Neue formulierungen und ihre verwendung
DE50206094D1 (de) Substituierte isoindole und ihre verwendung
DE69907802D1 (de) Thermisch wirkende Pflaster und seiner Verwendung
ATE419248T1 (de) Phenylsubstituierte 4-hydroxy-tetrahydropyridone und ihre verwendung als schädlingsbekämpungsmittel und herbizide
DE50112472D1 (de) Abstreifer und Gutförderer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition